In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 23rd, 2008 | 18 | Yes |
Popular Name: 1,3-bis(m-tolyl)guanidine 1,3-bis(m-tolyl)guanidine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.79 | 9.69 | -26.53 | 4 | 3 | 1 | 50 | 240.33 | 4 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
NMD3A-6-E | Glutamate [NMDA] Receptor Subunit 3A (cluster #6 Of 6), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMD3B-6-E | Glutamate [NMDA] Receptor Subunit 3B (cluster #6 Of 6), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMDE1-5-E | Glutamate [NMDA] Receptor Subunit Epsilon 1 (cluster #5 Of 5), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMDE2-5-E | Glutamate [NMDA] Receptor Subunit Epsilon 2 (cluster #5 Of 5), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMDE3-1-E | Glutamate [NMDA] Receptor Subunit Epsilon 3 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMDE4-6-E | Glutamate [NMDA] Receptor Subunit Epsilon 4 (cluster #6 Of 6), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
NMDZ1-6-E | Glutamate (NMDA) Receptor Subunit Zeta 1 (cluster #6 Of 6), Eukaryotic | Eukaryotes | 370 | 0.50 | Binding ≤ 10μM |
SGMR1-4-E | Sigma Opioid Receptor (cluster #4 Of 6), Eukaryotic | Eukaryotes | 84 | 0.55 | Binding ≤ 10μM |
Z104302-7-O | Glutamate NMDA Receptor (cluster #7 Of 7), Other | Other | 335 | 0.50 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 330 | 0.50 | Binding ≤ 1μM |
Z104302 | Z104302 | Glutamate NMDA Receptor | 335 | 0.50 | Binding ≤ 1μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 330 | 0.50 | Binding ≤ 1μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 330 | 0.50 | Binding ≤ 1μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 330 | 0.50 | Binding ≤ 1μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 330 | 0.50 | Binding ≤ 1μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 330 | 0.50 | Binding ≤ 1μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 330 | 0.50 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 43 | 0.57 | Binding ≤ 1μM |
NMDZ1_HUMAN | Q05586 | Glutamate (NMDA) Receptor Subunit Zeta 1, Human | 330 | 0.50 | Binding ≤ 10μM |
Z104302 | Z104302 | Glutamate NMDA Receptor | 335 | 0.50 | Binding ≤ 10μM |
NMD3A_HUMAN | Q8TCU5 | Glutamate [NMDA] Receptor Subunit 3A, Human | 330 | 0.50 | Binding ≤ 10μM |
NMD3B_HUMAN | O60391 | Glutamate [NMDA] Receptor Subunit 3B, Human | 330 | 0.50 | Binding ≤ 10μM |
NMDE1_HUMAN | Q12879 | Glutamate [NMDA] Receptor Subunit Epsilon 1, Human | 330 | 0.50 | Binding ≤ 10μM |
NMDE2_HUMAN | Q13224 | Glutamate [NMDA] Receptor Subunit Epsilon 2, Human | 330 | 0.50 | Binding ≤ 10μM |
NMDE3_HUMAN | Q14957 | Glutamate [NMDA] Receptor Subunit Epsilon 3, Human | 330 | 0.50 | Binding ≤ 10μM |
NMDE4_HUMAN | O15399 | Glutamate [NMDA] Receptor Subunit Epsilon 4, Human | 330 | 0.50 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 43 | 0.57 | Binding ≤ 10μM |
Description | Species |
---|---|
CREB phosphorylation through the activation of CaMKII | |
EPHB-mediated forward signaling | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Unblocking of NMDA receptor, glutamate binding and activation |